![Jason Amello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Amello
Direttore Finanziario/CFO presso
TSCAN THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/06/2026
Profilo
Jason A. Amello is currently Treasurer, Chief Financial & Accounting Officer at TScan Therapeutics, Inc. beginning in 2026.
Former roles include Director at Opexa Therapeutics, Inc.; Independent Director at Acer Therapeutics, Inc. from 2017 to 2023; Director at New England Baptist Hospital from 2015 to 2023; Senior Manager at Deloitte LLP (New York) from 1990 to 2000; Chief Financial Officer, Treasurer & Executive VP at Alaunos Therapeutics, Inc. in 2013; Treasurer, Chief Financial & Accounting Officer at Akebia Therapeutics, Inc. from 2013 to 2020; Chief Financial & Accounting Officer, Secretary at Candel Therapeutics, Inc. from 2022 to 2024; Chief Financial Officer at Saniona AB from 2020 to 2022; and Chief Accounting Officer, Senior VP & Controller at Genzyme Corp.
from 2000 to 2011.
Education includes undergraduate studies at Boston College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Jason Amello
| Società | Posizione | Inizio |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Direttore Finanziario/CFO | 29/01/2024 |
Precedenti posizioni note di Jason Amello
| Società | Posizione | Fine |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Direttore Finanziario/CFO | 12/01/2024 |
| ACER THERAPEUTICS INC. | Direttore/Membro del Consiglio | 17/11/2023 |
New England Baptist Hospital
 New England Baptist Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Direttore/Membro del Consiglio | 01/01/2023 |
| SANA AB | Direttore Finanziario/CFO | 01/04/2022 |
| AKEBIA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 29/06/2020 |
Formazione di Jason Amello
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
74
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, tax and financial advisory services | Commercial Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
New England Baptist Hospital
New England Baptist Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
